NeuroScientific

NSB.AX

Tags: AU Healthcare Biotechnology

NeuroScientific Biopharmaceuticals Limited Price (NSB.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

144,508,886

(0.723)%

Market Cap of NeuroScientific (NSB.AX)

Market cap:

As of , NSB.AX has a market cap of . This makes NSB.AX the 1569th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.033-0.078
Market Cap 5.93M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Anthony James Keating
IPO Date: July, 27, 2018
Country: AU
Currency: AUD
Headquaters: Cottesloe, WA
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: